BriaCell Therapeutics Corp
For the period ended Dec 17, 2024. Filed Dec 17, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 17, 2024 · Filed Dec 17, 2024
Contents
Performance Graph
The following performance graph compares the total cumulative return to a Shareholder who invested $100 in Shares on January 1, 2020, assuming reinvestment of dividends, with the cumulative total return on the S&P/TSX Venture Composite Index for each year following:
The Company’s executive compensation is affected by, but not directly based on, the Common Share price performance, and therefore NEOs’ compensation may not directly compare to the trend shown above.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.